Review
Open access
Sep 2026
Advances in KRAS-Targeted Therapies for Pancreatic Cancer
How KRAS drives pancreatic cancer is explained, the main direct and indirect treatment approaches are summarized, and a major challenge is highlighted: tumors often develop resistance when KRAS inhibitors are used alone.
S. Peshin, A. Zahid, E. Takrori et al.
· Cancers · 0 citations